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1. Introduction
Fanconi anemia (FA) is a rare disease, with an estimated frequency of 1 to 5 per 1,000,000 births, which may increase in some ethnic group (like Ashkenazi Jewish and Gypsy). It’s an
autosomal recessive disease that may have an X-linked transmission. Patients with FA may have congenital malformations, bone marrow failure, hypersensitivity to clastogenic agents,
chromosomal fragility, and increased susceptibility to oncological diseases. Due to the great complexity of this pathology, the first approach to diagnosis consists of the detection of
chromosomal aberrations (breaks, structural rearrangements, rings) in peripheral blood cells in culture with clastogenic agent such as diepoxybutane (DEB) or mitomycin C (MMC).
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2. Objective
We intend to present the results of chromosome instability studies induced by DEB and
MMC performed in our institution.
3. Methods
The analysis of a retrospective series of 37 years (1980-2017) of 274 samples sent to the
cytogenetic laboratory with suspicion of FA and 28 samples of relatives of patients with FA
were performed. In total, 265 samples of peripheral blood (PB), 3 of skin biopsy, 3 of
amniotic fluid, 1 of cord blood and 2 of marrow blood were analyzed (see Fig. 1).
The samples were processed according to the established protocol for the chromosomal
analysis of fracture associated diseases, including cell culture with MMC and / or DED
stimulation for each biological product, followed by microscopic analysis with determination
of the DEB-induced chromosomal instability and / or MMC according to the protocol
established by the International Fanconi Anemia Registry (IFAR).
5. Conclusion
 In this study, 41 new cases were identified with FA, mainly from the Lisbon and Tagus
Valley, some specific cases from the Autonomous Region of Azores, central region of
Portugal and from the Portuguese-speaking African countries (PALOP).
 This study evidences that most cases are underdiagnosed due to phenotypic overlap
with other syndromes. On the other hand this overlap, justifies the very high
percentage of negative FA obtained.
 Within the FA group, there are samples that, despite presenting a phenotype similar
to that of a patient with FA, present an abnormal karyotype (Tab.1). For this reason
and as a form of primary screening, a constitutional karyotype should be considered
simultaneously with the Fanconi Anemia research.
 These results do not allow to estimate a frequency of patients with FA in Portugal,
since it does not include individuals from all Portuguese regions, on the other hand
two individuals of PALOP origin are included.
 It would be interesting to carry out Next generation sequencing on the Fanconi
positive samples in order to obtain in a single assay the analysis of the various genes
involved in the pathology thus identifying the genetic change causing the disease.
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4. Results
 The mean age at diagnosis of FA patients was 7 years, with a slight predominance of
females (Fig. 2).
 In the 274 analyzed samples, 39 cases with FA were identified. (Fig. 3)
 In the cytogenetic studies of relatives with FA, 2 positive cases were identified.
 Therefore, we can say that we evaluate 302 samples in which we found 41 new
cases of FA.
 In 6 samples of suspected FA, were observed abnormal karyotypes (Table 1).
Fig. 1: Explanatory scheme of the samples analyzed over 37 years (1980 to 2017).
Tab. 1: Abnormal karyotypes obtained from the 302 samples analysed with suspicion of FA.
Sample
Nº
Clinical
Information
Overlap
with FA
phenotype
FA Karyotype
Phenotype vs
karyotype
(Bibliographic data)
I
•Bilateral agenesis
of the radio
+
-
mos47,XY,+7[3]/
46,XY[47]
short6
•Prominence of
frontal bosses
- Clinodactyly6
•Dysmorphic hands + Body asymmetry6
•No blood count
changes
- Triangular Facies6
II
•Psycho-motor
development delay
+
-
46,XY,dup(2)
(p23.1p24.3).ish
dup(2)(wcp2+)
Psycho-motor
Development Delay7
• Weight and height
less than P5 since 6
months
+ Microcephaly7
•Low thumb
implantation
+ Prominent forehead7
•Other small
dysmorphic
+ Facial dysmorphisms7
III
• Malformations of
the upper limbs
+ -
47,XX,+mar[2]/
46,XX[28]
-
IV
•Thin
thrombocytopenia +
macrocytosis
+
-
46,X,i(X)(p10)[11]/4
6,XX[39]
Pancytopenia with
marked
thrombocytopenia8
• ↑ Fetal Hb +
• Focomelia + Hematologic diseases8
•LCA (Congenital
Amaurose Leber)
- Apnea8
•Poor weight
evolution
+ Hypotonia8
•Short + Growth retardation8
V
•Low set ears +
-
47,XY,+mar[6]/
46,XY[44]
-•Short +
•Coffee au lait spots +
VI
•Growth retardation +
-
46,XY,t(7;20)
(p15;p13)[30]
In the short arm of cr. 7
in p15 is an ETV6
partner gene, the
ANLN, which may
induce a hematological
change in some way.
On the other hand, on
chromosome 20 in p13
there are cell cycle
regulator genes that
together with ANLN
may somehow induce
marrow failure.9,10
•Single kidney to
the left
+
•Medullary Failure +
Fig. 3: Graph with the number of patients identified with FA.
Fig. 2: Informative graph of the prevalence of female subjects (F) vs. male (M) with FA.
274 samples 
• 265 samples from PB
• 3 samples from skin biopsy
• 3 samples from amniotic fluid
• 1 samples from cord blood
• 2 samples from marrow blood
+
28 family
samples
• 3 failures
• 25 samples from PB
302 samples
